ResMed RMD Cash Flow Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $1.52B+15.7% | $1.49B+19.0% | $1.44B+29.2% | $1.4B+37.2% | $1.31B+37.0% | ||
| $220.19M+23.3% | $204.89M+14.9% | $201.44M+14.0% | $198.47M+12.2% | $178.52M-0.8% | ||
| $101.64M+15.1% | $98.97M+17.0% | $92.67M+13.2% | $91.66M+14.3% | $88.3M+12.2% | ||
| $1.89B+14.3% | $1.91B+29.7% | $1.88B+30.7% | $1.75B+25.0% | $1.65B+37.9% | ||
| $135.74M+61.3% | $122.89M+45.3% | $114.99M+31.8% | $89.87M-9.6% | $84.16M-22.8% | ||
| —— | —— | $139.77M+362% | $139.25M+4.3% | $20.37M-82.3% | ||
| -$295.26M-162% | -$269.02M-136% | -$254.77M-115% | -$200.05M+25.8% | -$112.84M+58.2% | ||
| $340.16M+12.0% | $330.63M+11.5% | $320.74M+10.7% | $310.88M+10.1% | $303.84M+9.9% | ||
| $600.05M+140% | $500.06M+122% | $400.03M+100.0% | $300.03M+100% | $250.02M+150% | ||
| —— | $10M-98.2% | $10M-98.5% | $40M-95.2% | $335M-50.7% | ||
| -$907.75M-8.6% | -$796.58M+22.5% | -$685.77M+38.7% | -$606.25M+45.8% | -$835.65M— | ||
| $727.8M+4.7% | $895.13M+187% | $957.49M+341% | $971.09M+9,175% | $694.8M+6,837% | ||
| $1.75B+11.8% | $1.79B+28.7% | $1.77B+30.7% | $1.66B+27.6% | $1.57B+44.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ResMed generate?
- ResMed (RMD) generated $1.9B in operating cash flow over the trailing twelve months.
- What is ResMed's free cash flow?
- After $135.7M of capital expenditures, ResMed's free cash flow was $1.8B over the trailing twelve months, up 11.8% year over year.
- Where does ResMed's cash flow data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
